CHIP mutation

Last updated on: 10.04.2025

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

CHIP is the acronym for "Clonal Hematopoiesis of Indeterminate Potential" and means that certain blood stem cells have mutations. This allows them to multiply easily and form a clone population in the blood. CHIP mutations are somatic (non-inherited) mutations that occur in genes that are also frequently altered in hematologic neoplasias, e.g.:

  • DNMT3A
  • TET2
  • ASXL1

General informationThis section has been translated automatically.

CHIP mutations are often found by chance in older people. They do not cause any symptoms or disease - but can slightly increase the risk of later blood diseases (e.g. leukemia).

Why are CHIP mutations important in oncology? In ctDNA analyses (blood tests for tumor diagnostics), CHIP mutations can be mistaken for tumor mutations because both occur in the blood. This can lead to false-positive results.

LiteratureThis section has been translated automatically.

  1. Marnell CS et al. (2021) Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease. J Mol Cell Cardiol 161:98-105.

Last updated on: 10.04.2025